Compositions and methods for preventing and treating mucositis and weight loss
AssigneeST IP Holding AG
InventorPatrick T. Prendergast
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; and a pharmaceutical carrier, which promotes association with the outer wall of a subject's digestive tract are described as well as their uses in treating and preventing mucositis and cachexia.
Claims19
1-101. (canceled)
A pharmaceutical composition comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione (oltipraz) or an analogue, derivative, metabolite, prodrug, solvate or pharmaceutically acceptable salt and a pharmaceutical carrier, which promotes association of the 5-[2-pyrazinyl]-4-methyl-1,2-3-thione (oltipraz) or an analogue, derivative, metabolite, prodrug, solvate or pharmaceutically acceptable salt with the outer wall of a subject's digestive tract.
Dependencies are inferred from the claim text.